How do medical practices order compounded formulations through ExaVeyra?

ExaVeyra refers licensed prescribers to our 503A pharmacy partner. A licensed prescriber creates a portal account and verifies their NPI, and our team reviews the practice before releasing the formulary and pricing. Each preparation is then compounded by a licensed 503A pharmacy against a valid prescription for an individual patient. ExaVeyra does not hold or resell compounded preparations.

What quality documentation comes with a compounded formulation?

A certificate of analysis covering purity, potency and, for sterile preparations, sterility is available on request for every lot, together with the lot number. Our organic chemist reviews the documentation before a formulation is added to the formulary.

Are compounded formulations sourced compliantly?

Each preparation is compounded by a 503A pharmacy licensed by its state Board of Pharmacy, against a valid prescription for an individual patient, with documentation that supports your practice's recordkeeping. Practitioners prescribe within their own scope and regulatory obligations. Our team can walk your practice through how the service works before your first prescription.

What formats are available?

Depending on the compound, the pharmacy prepares injectable, capsule, tablet, troche, cream and solution formats. Strengths, fill volumes and beyond-use dates for each preparation are listed in the formulary released to verified practices.

How are compounded preparations shipped and stored?

The dispensing 503A pharmacy ships each prescription in temperature-controlled, lot-tracked packaging, with the storage conditions and beyond-use date on the label. ExaVeyra does not hold compounded preparations.

503A Peptide and NAD+ Formulary for Prescribing Practices

This formulary is for licensed prescribers. ExaVeyra refers practices to its 503A pharmacy partner, which dispenses NAD+, glutathione and other compounded preparations on a patient-specific prescription in the states it is licensed to ship into. Each preparation's supplier documentation is reviewed by an organic chemist, and a certificate of analysis is available on request. Practices can apply or ask a question without an NPI; verification unlocks the full formulary with strengths, fills and beyond-use dates.

Organic Chemist-Reviewed503A, Per PrescriptionCOA on RequestLot TrackingNPI-Verified Access

Apply for Access Request a Quote

Browse by category

Every 503A Compound, One Searchable Library

Filter by therapeutic group or search by name, mechanism, or research area. Each compound has a dedicated page ready for peer-reviewed enrichment.

Showing 34 of 34 compounds · scroll the list to see them all

Benzocaine 20% / Lidocaine 10% / Tetracaine 10%

Benzocaine, lidocaine and tetracaine topical combination

Ester and Amide Anesthetic Combination

Format: Topical Cream
Strengths: 60 mL Pump
Beyond-use: 180 days
Group: Topical Numbing

Research summary

Three surface anesthetics in one vehicle, spanning both structural classes. Benzocaine and tetracaine carry an ester linkage while lidocaine carries an amide, and the two classes are cleared by different routes.

View compound details ›6 citations

GHK-Cu 3% / SNAP-8 1% / Niacinamide 3% Serum

GHK-Cu, acetyl octapeptide-3 and niacinamide topical serum

Multi-Peptide Topical Serum

Format: Topical
Strengths: (GHK-Cu 3% / SNAP-8 1% / Niacinamide 3%) 30 mL
Beyond-use: 180 days
Group: Skin & Aesthetics

Research summary

Three actives with three unrelated mechanisms in one vehicle: a copper-binding matrikine, an octapeptide patterned on a SNARE protein, and a nicotinamide precursor feeding the NAD salvage pathway.

View compound details ›5 citations

T4/T3 Combination

Levothyroxine and liothyronine combination

Iodinated Thyroid Hormone Combination

Format: Capsule (IR)
Strengths: 19 mcg/4.5 mcg IR Capsule · 28.5 mcg/6.8 mcg IR Capsule · 38 mcg/9 mcg IR Capsule · 50 mcg/10 mcg IR Capsule · 50 mcg/15 mcg IR Capsule · 57 mcg/13.5 mcg IR Capsule · 76 mcg/18 mcg IR Capsule · 95 mcg/22.5 mcg IR Capsule · 114 mcg/27 mcg IR Capsule · 152 mcg/36 mcg IR Capsule
Beyond-use: Per prescription
Group: Hormone Optimization

Research summary

Levothyroxine and liothyronine are iodinated tyrosine derivatives separated by a single iodine atom. T4 circulates largely as a prohormone, and which iodine a deiodinase removes decides whether it becomes active T3 or inactive reverse T3.

View compound details ›4 citations

NAD+ (Nicotinamide Adenine Dinucleotide)

Nicotinamide Adenine Dinucleotide

Mitochondrial Coenzyme

Format: Injectable and Nasal Spray
Strengths: 100 mg/mL (10 mL) · 10 mg/0.1 mL (15 mL) Nasal Spray
Beyond-use: 30 days or 90 days
Group: Vitamins & IV Solutions

Research summary

Coenzyme in the mitochondrial electron transport chain and an obligate substrate for sirtuins (SIRT1-7) and PARP enzymes involved in DNA repair, genomic stability, and metabolic signaling.

View compound details ›4 citations

Methylcobalamin (B12)

Methylcobalamin (mecobalamin)

Organometallic Cobalamin Coenzyme

Format: Injectable
Strengths: 5 mg/mL (10 mL) · 5 mg/mL (30 mL)
Beyond-use: 90 days
Group: Vitamins & IV Solutions

Research summary

A corrin ring holding a cobalt atom, with a methyl group bound directly to that cobalt. The cobalt-carbon bond makes this one of very few organometallic compounds in human biochemistry, and it is the reason the vial is light-protected.

View compound details ›4 citations

GHK-Cu Biocosmetic Cream (GHK-Cu 3% / Estriol 0.3%)

GHK-Cu and estriol topical cream

Copper Peptide and Estrogen Combination

Format: Topical Cream
Strengths: (GHK-Cu 3% / Estriol 0.3%) 30 g
Beyond-use: 180 days
Group: Skin & Aesthetics

Research summary

GHK-Cu paired with estriol at low percentage. Estriol is 16-alpha-hydroxy estradiol, and that third hydroxyl shortens how long it occupies the estrogen receptor, which is most of what separates it from estradiol.

View compound details ›4 citations

DHEA

Dehydroepiandrosterone

Adrenal Hormone Precursor

Format: Capsule
Strengths: 25 mg Capsule · 50 mg Capsule · 100 mg Capsule
Beyond-use: Per prescription
Group: Hormone Optimization

Research summary

Adrenal-derived C19 steroid precursor to both androgens and estrogens. Peripheral conversion is tissue-specific and declines with age.

View compound details ›3 citations

Low Dose Naltrexone

Opioid Receptor Modulation

Format: Capsule
Strengths: 1.5 mg Capsule
Beyond-use: Per prescription
Group: Hormone Optimization

Research summary

At sub-therapeutic doses, naltrexone transiently blocks opioid receptors, prompting compensatory upregulation of endogenous endorphin production and modulating microglial signaling.

View compound details ›3 citations

Glutathione

gamma-L-Glutamyl-L-cysteinylglycine

Endogenous Antioxidant Tripeptide

Format: Injectable
Strengths: 200 mg/mL (10 mL) · 200 mg/mL (30 mL)
Beyond-use: 90 days
Group: Vitamins & IV Solutions

Research summary

Endogenous tripeptide antioxidant. Primary substrate for glutathione peroxidase and glutathione S-transferase in phase II hepatic detoxification and reactive oxygen species neutralization.

View compound details ›3 citations

GHK-Cu 1%

Glycyl-L-histidyl-L-lysine copper(II) complex

Copper Tripeptide Complex

Format: Scalp Solution
Strengths: Solution 30 mL
Beyond-use: 35 days
Group: Hair Restoration

Research summary

Endogenous tripeptide-copper complex studied in skin remodeling, angiogenesis, hair-follicle biology and matrix metalloproteinase modulation.

View compound details ›3 citations

Methylene Blue 0.0064% / Estriol 0.003% Cream

Methylthioninium chloride topical

Mitochondrial Electron Cycler

Format: Topical Cream
Strengths: (Methylene Blue 0.0064% / Estriol 0.003%) 30 g
Beyond-use: 180 days
Group: Skin & Aesthetics

Research summary

Methylene blue cycles between oxidized and reduced forms, donating electrons to the mitochondrial electron transport chain and reducing reactive oxygen species in skin models.

View compound details ›3 citations